Prosecution Insights
Last updated: April 19, 2026

Inscripta Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18491049 DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING MONTANARI, DAVID A 1632 Non-Final OA Oct 20, 2023
18240550 METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING BRETZ, COREY LANE 1635 Non-Final OA Aug 31, 2023
18348128 MAD NUCLEASES REGLAS, GEORGIANA C 1651 Non-Final OA Jul 06, 2023
18166868 CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI RYAN, DOUGLAS CHARLES 1635 Non-Final OA Feb 09, 2023
17726250 SYSTEM AND METHOD FOR GENE EDITING CASSETTE DESIGN MINCHELLA, KAITLYN L 1685 Non-Final OA Apr 21, 2022
17692108 SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST LEITH, NANCY J 1636 Non-Final OA Mar 10, 2022

Managing Inscripta Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month